A new study reveals that an AURKA-driven phosphorylation and SUMOylation cascade stabilizes the protein SPICE1, fueling ...
A retrospective study of nearly 300 kidney cancer patients links bone metastases to dramatically accelerated skeletal muscle ...
Oct 23 (Reuters) - Inhibrx Biosciences (INBX.O), opens new tab said on Thursday its experimental drug helped slow the progression of a rare and aggressive bone cancer in a mid-stage trial, sending its ...
Researchers have developed a magnetic nanomaterial that can kill bone cancer cells and support bone regeneration at the same time. The material heats up under a magnetic field to destroy tumors, while ...
A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of East Anglia and University of Sheffield. Cancer that starts in the bones, ...
The CCTG BR.34 trial was a randomized phase II study assessing durvalumab plus tremelimumab, with or without platinum-doublet chemotherapy, in 301 patients with metastatic NSCLC. Patients were ...
Real-world prevalence and outcomes of androgen receptor ligand-binding domain mutations in prostate cancer. Real-world use of bone-modifying agents (BMA) in patients (pts) with metastatic ...
A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of East Anglia and University of Sheffield. Cancer that starts in the bones, ...
(Koto_feja/E+/Getty Images) A new clinical trial reveals intriguing results about a potential treatment for high-risk smoldering multiple myeloma, a pre-cancerous bone marrow condition that brings an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results